from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0433/-

LFCtreatmentdescriptionclass of inhibitor

0.385

Amikacinug/mL Amikacintranslation

-0.174

Cap5-10ug/mL Capreomycintranslation

-0.544

Rox10-50 ug/mL Roxithromycintranslation

0.721

SM2-5 ug/mL Streptomycintranslation

-2.193

Tet5-10 ug/mL Tetracyclinetranslation

-0.118

Rif0.2-5ug/mL Rifampicintranscription

0.345

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.001

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.156

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.647

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.178

Clofazimine10-13 ug/mL Clofaziminerespiration

0.274

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.527

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.665

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.704

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.312

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.108

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.299

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.250

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.017

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.623

KCN5-20 ug/mL Potassium cyaniderespiration

-0.307

NaN30.2-2 mM Sodium aziderespiration

0.161

Nigericin50 uM Nigericinrespiration

-0.980

TRC10-150 ug/mL Triclosanrespiration

-1.329

TRZ10-25 ug/mL Thioridazinerespiration

-2.994

Valinomycin0.5-10 uM Valinomycinrespiration

0.533

ZnSO42 mM ZnSO4respiration

-0.277

menadione6-10 ug/mL Menadionerespiration

0.061

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.785

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.137

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.671

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.398

NRP_1Non-replicating persistence stage 1dosRassociated

0.448

Amp0.2mg/mL AmpicillincellWall

0.171

Cephalexin20-100 ug/mL CephalexincellWall

0.751

Cerulenin0.32-5 ug/mL CerulenincellWall

0.839

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.573

EMB10-20 ug/mL EthambutolcellWall

0.552

Eta12-40 ug/mL EthionamidecellWall

0.504

INH0.2-0.4 ug/mL IsoniazidcellWall

0.272

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.158

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.472

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.474

BZA0.12 mg/mL BenzamidearomaticAmides

0.697

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.313

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.247

H2O24 mM hydrogen peroxideDNAdamaging

0.590

Levo10 ug/mL LevofloxacinDNAdamaging

0.826

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.040

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.634

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.832

UVUV-irradiationDNAdamaging

0.254

ARP41-4 ug/mL Antitubercular compound ARP4?

0.425

Antimycin12.5-50 ug/mL Antimycin A?

0.250

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.295

PA_110-50 ug/mL Antitubercular compound PA-1?

0.393

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.491

PA8240.2-2 ug/mL PA-824?

-1.065

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.055

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.351

Verapamil50 uM Verapamil?

0.501

mercaptoethanol2 mM 2-Mercaptoethanol?

0.361

methoxatin10-20 ug/mL Methoxatin?